Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.

Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH.

J Invest Dermatol. 2013 Feb;133(2):429-40. doi: 10.1038/jid.2012.292.

2.

Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.

Im M, Kim SY, Sohn KC, Choi DK, Lee Y, Seo YJ, Kim CD, Hwang YL, Zouboulis CC, Lee JH.

J Invest Dermatol. 2012 Dec;132(12):2700-8. doi: 10.1038/jid.2012.202.

3.

Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.

Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang CM.

J Invest Dermatol. 2010 Apr;130(4):985-94. doi: 10.1038/jid.2009.384.

4.

SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.

Fernandéz JR, Rouzard K, Voronkov M, Feng X, Stock JB, Stock M, Gordon JS, Shroot B, Christensen MS, Pérez E.

J Cosmet Dermatol. 2012 Dec;11(4):272-8. doi: 10.1111/jocd.12002.

PMID:
23174050
5.

[Use of organic acids in acne and skin discolorations therapy].

Kapuścińska A, Nowak I.

Postepy Hig Med Dosw (Online). 2015 Mar 22;69:374-83. Review. Polish.

6.

Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.

Sato T, Shirane T, Noguchi N, Sasatsu M, Ito A.

J Dermatol. 2012 Sep;39(9):774-80. doi: 10.1111/j.1346-8138.2012.01525.x.

PMID:
22394009
9.
10.

Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway.

Jung MK, Ha S, Son JA, Song JH, Houh Y, Cho E, Chun JH, Yoon SR, Yang Y, Bang SI, Kim M, Park HJ, Cho D.

Arch Dermatol Res. 2012 Oct;304(8):655-63. doi: 10.1007/s00403-012-1249-x.

PMID:
22684779
11.

Acne and Propionibacterium acnes.

Bojar RA, Holland KT.

Clin Dermatol. 2004 Sep-Oct;22(5):375-9. Review.

PMID:
15556721
12.

Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne.

Kwon HH, Yoon JY, Park SY, Min S, Kim YI, Park JY, Lee YS, Thiboutot DM, Suh DH.

J Invest Dermatol. 2015 Jun;135(6):1491-500. doi: 10.1038/jid.2015.29.

13.
14.

Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.

Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI, Cunliffe WJ.

Br J Dermatol. 2004 Sep;151(3):616-22.

PMID:
15377348
15.

Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.

Mendoza N, Hernandez PO, Tyring SK, Haitz KA, Motta A.

Int J Dermatol. 2013 Jun;52(6):688-92. doi: 10.1111/j.1365-4632.2011.05403.x.

PMID:
23451873
16.

Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.

Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB.

J Dermatol. 2011 Jul;38(7):667-73. doi: 10.1111/j.1346-8138.2010.01109.x.

PMID:
21352337
17.
18.
20.

The role of facial sebum secretion in acne pathogenesis: facts and controversies.

Youn SW.

Clin Dermatol. 2010 Jan-Feb;28(1):8-11. doi: 10.1016/j.clindermatol.2009.03.011. Review.

PMID:
20082943
Items per page

Supplemental Content

Support Center